Photo from academic.microsoft.com
In BCR‐ABL1‐negative myeloproliferative neoplasms, myelofibrosis (MF) is either primary (PMF) or secondary (SMF) to polycythemia vera or essential thrombocythemia. MF is characterized by an increased risk of transformation to acute… Click to show full abstract
In BCR‐ABL1‐negative myeloproliferative neoplasms, myelofibrosis (MF) is either primary (PMF) or secondary (SMF) to polycythemia vera or essential thrombocythemia. MF is characterized by an increased risk of transformation to acute myeloid leukemia (AML) and a shortened life expectancy.
Keywords:
molecular characterization;
targeted molecular;
shows differences;
differences primary;
myelofibrosis;
characterization shows
Journal Title: Genes
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Genes
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!